Home Hpets

Hpets

In operation
Undisclosed
Pet Innovative Drug Developer
Basic
Enterprise Profile

Basic Information

Hpets Biotech (Chongqing) Co.,ltd was founded in 2022. Based in Chongqing, the company focuses on developing first-in-class and best-in-class innovative pet medications, with its sights set both within China and internationally. Currently, Hpets has developed a range of innovative products targeting chronic diseases, gastrointestinal diseases, metabolic disorders, and next-generation antibiotics for pets.
Hpets Biotech (Chongqing) Co.,ltd
Chongqing,China
15~50 people
September 22, 2022
info@hanpets.com

Enterprise Profile

Industrial Sector
Nutritional Supplement Manufacturing Health Supplement Manufacturing New Drug Development Production of Pharmaceutical Intermediates
Concept
Infectious Diseases Digestive System Diseases Therapeutic Products
Application Scenarios
Innovative Drugs